CIK 0001841387 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Candel Therapeutics, Inc.
Sign in to watch- Ticker
- CADL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 522214851
- Phone
- 617-916-5445
- Business address
- 117 KENDRICK STREET, SUITE 450, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,244,783
- in 2 filings, $3.2M under 10b5-1 plans
Net −$3,244,783. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-23 | Aguilar-Cordova Estuardo 10% owner | Returned to the company | −50,000 | $8.52 | $426K | 281,443 |
| 2024-12-20 | Aguilar-Cordova Estuardo 10% owner | Returned to the company | −100,000 | $9.00 | $900K | 373,512 |
| 2024-12-20 | Aguilar-Cordova Estuardo 10% owner | Returned to the company | −100,000 | $9.00 | $900K | 331,443 |
| 2024-12-16 | Manning Paul B Director | Purchase | +500,000 | $6.00 | $3.0M | 1,142,406 |
| 2024-12-16 | Manning Paul B Director | Purchase | +750,000 | $6.00 | $4.5M | 1,303,752 |
| 2024-12-12 | Aguilar-Cordova Estuardo 10% owner | Returned to the company | −200,000 | $10.04 | $2.0M | 473,512 |
| 2024-12-12 | Aguilar-Cordova Estuardo 10% owner | Returned to the company | −200,000 | $10.04 | $2.0M | 431,443 |
| 2024-12-11 | Aguilar-Cordova Estuardo 10% owner | Returned to the company | −200,000 | $8.53 | $1.7M | 673,512 |
| 2024-12-11 | Aguilar-Cordova Estuardo 10% owner | Returned to the company | −200,000 | $8.53 | $1.7M | 631,443 |
| 2024-12-06 | Aguilar-Cordova Estuardo 10% owner | Returned to the company | −20,000 | $5.23 | $105K | 91,335 |
| 2024-12-05 | Aguilar-Cordova Estuardo 10% owner | Returned to the company | −20,000 | $4.79 | $96K | 111,335 |
| 2024-12-04 | Aguilar-Cordova Estuardo 10% owner | Returned to the company | −20,000 | $4.46 | $89K | 131,335 |
| 2024-11-29 | Tyagarajan Seshu Chief Technology Officer | Sale | −20,392 | $4.56 | $93K | 125,657 |
| 2024-11-29 | Tak Paul Peter Chief Executive Officer | Sale | −48,847 | $4.56 | $223K | 294,788 |
| 2024-11-29 | Nichols William Garrett Chief Medical Officer | Sale | −13,935 | $4.56 | $63K | 100,547 |
| 2024-11-29 | Barone Francesca Chief Scientific Officer | Sale | −22,081 | $4.56 | $101K | 137,880 |
| 2024-11-25 | Aguilar-Cordova Estuardo 10% owner | Returned to the company | −20,000 | $4.97 | $99K | 151,335 |
| 2024-11-21 | Tak Paul Peter Chief Executive Officer | Option exercise | +12,900 | $1.55 | $20K | 343,635 |
| 2024-11-21 | Tak Paul Peter Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −12,900 | 1,763,968 | ||
| 2024-11-08 | Aguilar-Cordova Estuardo 10% owner | Returned to the company | −7,500 | $4.92 | $37K | 873,512 |
Page 6 of 13 · 249 trades